Global Radiotherapy Market is expected to reach USD 9.3 billion by 2024 | CAGR 7.5%

Global Radiotherapy Market is expected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Brief Sample Of the Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiotherapy-market#utm_source=Openpr&utm_campaign=Shubham

The major factors driving the growth of this market are rising incidence of cancer, increasing acceptance of adaptive radiation therapy (ART), growing pool of geriatric population and increasing number of cancer treatment facilities. These factors increase the demand for radiotherapy devices. On the other hand, high cost of radiotherapy equipments and lack of skilled professionals may hinder the growth of the market.

The global radiotherapy market is segmented on the basis of type, product type, indication, and geography.

The global radiotherapy market is segmented into three types, namely beam radiotherapy, brachytherapy and systematic radiotherapy. In 2017, the beam radiotherapy segment is expected to dominate the market with a share around 75.0% and is expected to continue this trend till 2024. Radiotherapy Market is segmented into beam radiotherapy, brachytherapy and systematic radiotherapy. The beam radiotherapy is segmented into IGRT, IMRT, VMAT, tomotherapy, stereotactic technology and 3D conformal technology. The brachytherapy is segmented into LDR and HDR.

Read more about the market @ http://databridgemarketresearch.com/reports/global-radiotherapy-market/#utm_source=Openpr&utm_campaign=Shubham

On the basis of product type, the market is segmented into external beam radiotherapy, internal radiotherapy products, radiotherapy softwares and systematic radiotherapy. External beam radiotherapy is segmented into LINAC, CyberKnife, proton therapy and Gamma Knife. The proton beam is segmented into cyclotron and synclotron. The internal beam is segmented into seeds and afterloaders. The radiotherapy softwares is segmented into treatment planning softwares, dosage planning softwares, patient positioning softwares and image guiding softwares.

Based on indication, the market is segmented into prostate cancer, breast cancer, lung cancer, spine cancer, liver cancer, brain cancer and others.

Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-radiotherapy-market#utm_source=Openpr&utm_campaign=Shubham

Based on geography the global molecular spectroscopy market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

The Global Radiotherapy Market Report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. The report includes market shares of prefilled syringes market for global, Europe, North America, Asia Pacific and South America.

Speak to our Analyst Call: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-radiotherapy-market#utm_source=Openpr&utm_campaign=Shubham

Some of the major players operating in this market are
• Varian Medical Systems, Inc.
• Elekta AB
• Accuray, Inc.
• CIVCO Medical Solutions
• Brainlab AG
• C. R. Bard, Inc.
• IsoRay Medical, Inc.
• Nordion, Inc.
• RaySearch Laboratories AB
• PRECISIS AG
• Mevion Medical Systems, Inc.
• TechnicasRadiofiscas S.L.
• Hitachi, Ltd.
• Sumitomo Heavy Industries, Ltd.
• Mitsubishi Electric Corporation
• ProNova Solutions, LLC
• ProTom International

Ask for TOC: http://databridgemarketresearch.com/toc/?dbmr=global-radiotherapy-market#utm_source=Openpr&utm_campaign=Shubham

Related Report

APAC Point-of-Care Testing (POCT) Market – Trends and Forecast To 2024

APAC Point-of-care Testing (POCT) Market By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others),By Prescription Mode (Prescription Based Testing & Over-The-Counter Testing),By Distribution Channel (Direct Tenders & Retail),By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), By Country (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Singapore, Indonesia, Philippines and Rest of APAC) – Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/apac-point-care-testing-poct-market-trends-forecast-2024/#utm_source=Openpr&utm_campaign=Shubham

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor:investors@databridgemarketresearch.com
Visit Blog http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.